Supplementing Neuro-Energy to Aid Cognition

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorUniversity of Pennsylvania

About this trial

It is projected that by 2030, one in every five Americans will be of retirement age, and this demographic shift is expected to result in more people suffering from dementia. A key feature of the brain is its need for a constant supply of glucose and oxygen to meet the high energy costs of mental activity. This study aims to develop clinically practical, noninvasive imaging methods based on combined positron emission tomography and magnetic resonance imaging to assess brain energy in order to better understand how this critical component of brain health is impacted by aging.

Eligibility criteria

Qualifiers

Healthy Participants: Males and females, Age 21 - 80 years, BMI of 18.5-30

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Ketogenic Supplement
  • Placebo Drink

Treatment groups

17 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Pennsylvania

Lead sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborator

University of Western Ontario, Canada

Collaborator